ONPATTRO DIN 02489252
Status: Marketed
Holder: ALNYLAM NETHERLANDS B.V.
Molecule: PATISIRAN (PATISIRAN SODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | PATISIRAN (PATISIRAN SODIUM) 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N07XX12 PATISIRAN |
| Original market date | 25-Jul-2019 |
| Current status date | 25-Jul-2019 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22251 | 2019-06-07 | New Drug Submission (NDS) |